Orthobunyaviruses and innate immunity induction: AlieNSs vs. PredatoRRs

European Journal of Cell Biology

Volumn 94, Issue 7-9, 2015, Pages 384-390

  Schoen, Andreas ^a   Weber, Friedemann ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Bunyamwera; Interferon induction; La Crosse; MRNA elongation; NSs; Orthobunyaviruses; Pathogen recognition receptors; RIG I; RNA polymerase II; RPB1 degradation; Schmallenberg

Indexed keywords

GENOMIC RNA; PATTERN RECOGNITION RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; RNA POLYMERASE II; VIRUS PROTEIN; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN; INTERFERON;

ARTHROPOD; COMPARATIVE STUDY; CYTOPLASM; GENE EXPRESSION; INNATE IMMUNITY; MAMMAL; MOSQUITO; NONHUMAN; ORTHOBUNYAVIRUS; PRIORITY JOURNAL; SHORT SURVEY; VIRUS TRANSMISSION; ANIMAL; ANTAGONISTS AND INHIBITORS; BUNYAVIRUS INFECTION; GENETICS; HUMAN; IMMUNOLOGY; LIVESTOCK; METABOLISM; SIGNAL TRANSDUCTION; VIROLOGY;

ARTHROPODA; MAMMALIA;

ANIMALS; BUNYAVIRIDAE INFECTIONS; DEAD-BOX RNA HELICASES; HUMANS; IMMUNITY, INNATE; INTERFERONS; LIVESTOCK; ORTHOBUNYAVIRUS; RNA POLYMERASE II; SIGNAL TRANSDUCTION; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84939650792     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2015.06.001     Document Type: Short Survey

References (107)

1. Abraham G., Pattnaik A.K. Early RNA synthesis in Bunyamwera virus-infected cells. J. Gen. Virol. 1983, 64(Pt 6):1277-1290.
2. Anindya R., Aygun O., Svejstrup J.Q. Damage-induced ubiquitylation of human RNA polymerase II by the ubiquitin ligase Nedd4, but not Cockayne syndrome proteins or BRCA1. Mol. Cell 2007, 28:386-397.
3. Ariza A., Tanner S.J., Walter C.T., Dent K.C., Shepherd D.A., Wu W., Matthews S.V., Hiscox J.A., Green T.J., Luo M., Elliott R.M., Fooks A.R., Ashcroft A.E., Stonehouse N.J., Ranson N.A., Barr J.N., Edwards T.A. Nucleocapsid protein structures from orthobunyaviruses reveal insight into ribonucleoprotein architecture and RNA polymerization. Nucleic Acids Res. 2013, 41:5912-5926.
4. Barr J.N. Bunyavirus mRNA synthesis is coupled to translation to prevent premature transcription termination. RNA 2007, 13:731-736.
5. Barry G., Varela M., Ratinier M., Blomstrom A.L., Caporale M., Seehusen F., Hahn K., Schnettler E., Baumgartner W., Kohl A., Palmarini M. NSs protein of Schmallenberg virus counteracts the antiviral response of the cell by inhibiting its transcriptional machinery. J. Gen. Virol. 2014, 95:1640-1646.
6. Beer M., Conraths F.J., van der Poel W.H. 'Schmallenberg virus'-a novel orthobunyavirus emerging in Europe. Epidemiol. Infect. 2013, 141:1-8.
7. Bellocq C., Kolakofsky D. Translational requirement for La Crosse virus S-mRNA synthesis: a possible mechanism. J. Virol. 1987, 61:3960-3967.
8. Blakqori G., Delhaye S., Habjan M., Blair C.D., Sanchez-Vargas I., Olson K.E., Attarzadeh-Yazdi G., Fragkoudis R., Kohl A., Kalinke U., Weiss S., Michiels T., Staeheli P., Weber F. La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J. Virol. 2007, 81:4991-4999.
9. Blakqori G., Kochs G., Haller O., Weber F. Functional L polymerase of La Crosse virus allows in vivo reconstitution of recombinant nucleocapsids. J. Gen. Virol. 2003, 84:1207-1214.
10. Blakqori G., van Knippenberg I., Elliott R.M. Bunyamwera orthobunyavirus S-segment untranslated regions mediate poly(A) tail-independent translation. J. Virol. 2009, 83:3637-3646.
11. Blakqori G., Weber F. Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs. J. Virol. 2005, 79:10420-10428.
12. Borucki M.K., Kempf B.J., Blitvich B.J., Blair C.D., Beaty B.J. La Crosse virus: replication in vertebrate and invertebrate hosts. Microbes Infect./Institut Pasteur 2002, 4:341-350.
13. Bowden T.A., Bitto D., McLees A., Yeromonahos C., Elliott R.M., Huiskonen J.T. Orthobunyavirus ultrastructure and the curious tripodal glycoprotein spike. PLoS Pathog. 2013, 9:e1003374.
14. Bridgen A., Weber F., Fazakerley J.K., Elliott R.M. Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:664-669.
15. Briese T., Bird B., Kapoor V., Nichol S.T., Lipkin W.I. Batai and Ngari viruses: M segment reassortment and association with severe febrile disease outbreaks in East Africa. J. Virol. 2006, 80:5627-5630.
16. Calisher C.H. Medically important arboviruses of the United States and Canada. Clin. Microbiol. Rev. 1994, 7:89-116.
17. Carlton-Smith C., Elliott R.M. Viperin, MTAP44, and protein kinase R contribute to the interferon-induced inhibition of Bunyamwera Orthobunyavirus replication. J. Virol. 2012, 86:11548-11557.
18. Casamassimi A., Napoli C. Mediator complexes and eukaryotic transcription regulation: an overview. Biochimie 2007, 89:1439-1446.
19. Chowdhary R., Street C., Travassos da Rosa A., Nunes M.R., Tee K.K., Hutchison S.K., Vasconcelos P.F., Tesh R.B., Lipkin W.I., Briese T. Genetic characterization of the Wyeomyia group of orthobunyaviruses and their phylogenetic relationships. J. Gen. Virol. 2012, 93:1023-1034.
20. Colon-Ramos D.A., Irusta P.M., Gan E.C., Olson M.R., Song J., Morimoto R.I., Elliott R.M., Lombard M., Hollingsworth R., Hardwick J.M., Smith G.K., Kornbluth S. Inhibition of translation and induction of apoptosis by Bunyaviral nonstructural proteins bearing sequence similarity to reaper. Mol. Biol. Cell 2003, 14:4162-4172.
21. Conraths F.J., Peters M., Beer M. Schmallenberg virus, a novel orthobunyavirus infection in ruminants in Europe: potential global impact and preventive measures. N. Z. Vet. J. 2013, 61:63-67.
22. Copeland A.M., Altamura L.A., Van Deusen N.M., Schmaljohn C.S. Nuclear relocalization of polyadenylate binding protein during rift valley fever virus infection involves expression of the NSs gene. J. Virol. 2013, 87:11659-11669.
23. Degols G., Eldin P., Mechti N. ISG20, an actor of the innate immune response. Biochimie 2007, 89:831-835.
24. Delhaye S., Paul S., Blakqori G., Minet M., Weber F., Staeheli P., Michiels T. Neurons produce type I interferon during viral encephalitis. Proc. Natl. Acad. Sci. USA 2006, 103:7835-7840.
25. Dong H., Li P., Elliott R.M., Dong C. Structure of Schmallenberg orthobunyavirus nucleoprotein suggests a novel mechanism of genome encapsidation. J. Virol. 2013, 87:5593-5601.
26. Eifan S., Schnettler E., Dietrich I., Kohl A., Blomstrom A.L. Non-structural proteins of arthropod-borne bunyaviruses: roles and functions. Viruses 2013, 5:2447-2468.
27. Elliott R.M. Orthobunyaviruses: recent genetic and structural insights. Nat. Rev. Microbiol. 2014, 12:673-685.
28. Elliott R.M., Blakqori G., van Knippenberg I.C., Koudriakova E., Li P., McLees A., Shi X., Szemiel A.M. Establishment of a reverse genetics system for Schmallenberg virus, a newly emerged orthobunyavirus in Europe. J. Gen. Virol. 2013, 94:851-859.
29. Elliott R.M., Weber F. Bunyaviruses and the type I interferon system. Viruses 2009, 1:1003-1021.
30. Fensterl V., Sen G.C. Interferon-induced ifit proteins: their role in viral pathogenesis. J. Virol. 2015, 89:2462-2468.
31. Fontana J., Lopez-Montero N., Elliott R.M., Fernandez J.J., Risco C. The unique architecture of Bunyamwera virus factories around the Golgi complex. Cell. Microbiol. 2008, 10:2012-2028.
32. Frese M., Kochs G., Feldmann H., Hertkorn C., Haller O. Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J. Virol. 1996, 70:915-923.
33. Fuller F., Bhown A.S., Bishop D.H. Bunyavirus nucleoprotein, N, and a non-structural protein, NSS, are coded by overlapping reading frames in the S RNA. J. Gen. Virol. 1983, 64(Pt 8):1705-1714.
34. Fuller F., Bishop D.H. Identification of virus-coded nonstructural polypeptides in bunyavirus-infected cells. J. Virol. 1982, 41:643-648.
35. Gauci P.J., McAllister J., Mitchell I.R., Boyle D.B., Bulach D.M., Weir R.P., Melville L.F., Gubala A.J. Genomic characterisation of three mapputta group viruses, a serogroup of Australian and papua new guinean bunyaviruses associated with human disease. PloS One 2015, 10:e0116561.
36. Gerrard S.R., Li L., Barrett A.D., Nichol S.T. Ngari virus is a Bunyamwera virus reassortant that can be associated with large outbreaks of hemorrhagic fever in Africa. J. Virol. 2004, 78:8922-8926.
37. Gomes N.P., Bjerke G., Llorente B., Szostek S.A., Emerson B.M., Espinosa J.M. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program. Genes Dev. 2006, 20:601-612.
38. Groseth A., Weisend C., Ebihara H. Complete genome sequencing of mosquito and human isolates of Ngari virus. J. Virol. 2012, 86:13846-13847.
39. Habjan M., Andersson I., Klingstrom J., Schumann M., Martin A., Zimmermann P., Wagner V., Pichlmair A., Schneider U., Muhlberger E., Mirazimi A., Weber F. Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PloS One 2008, 3:e2032.
40. Haddow A.D., Odoi A. The incidence risk, clustering, and clinical presentation of La Crosse virus infections in the eastern United States, 2003-2007. PloS One 2009, 4:e6145.
41. Haller O., Staeheli P., Schwemmle M., Kochs G. Mx GTPases: dynamin-like antiviral machines of innate immunity. Trends Microbiol. 2015, 23:154-163.
42. Hart T.J., Kohl A., Elliott R.M. Role of the NSs protein in the zoonotic capacity of Orthobunyaviruses. Zoonoses Public Health 2009, 56:285-296.
43. Hofmann H., Li X., Zhang X., Liu W., Kuhl A., Kaup F., Soldan S.S., Gonzalez-Scarano F., Weber F., He Y., Pohlmann S. Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines. J. Virol. 2013, 87:4384-4394.
44. Hollidge B.S., Nedelsky N.B., Salzano M.V., Fraser J.W., Gonzalez-Scarano F., Soldan S.S. Orthobunyavirus entry into neurons and other mammalian cells occurs via clathrin-mediated endocytosis and requires trafficking into early endosomes. J. Virol. 2012, 86:7988-8001.
45. Hubalek Z., Rudolf I., Nowotny N. Arboviruses pathogenic for domestic and wild animals. Adv. Virus Res. 2014, 89:201-275.
46. Jonkers I., Lis J.T. Getting up to speed with transcription elongation by RNA polymerase II. Nat. Rev. Mol. Cell Biol. 2015, 16:167-177.
47. Kallfass C., Ackerman A., Lienenklaus S., Weiss S., Heimrich B., Staeheli P. Visualizing production of beta interferon by astrocytes and microglia in brain of La Crosse virus-infected mice. J. Virol. 2012, 86:11223-11230.
48. Klemm C., Reguera J., Cusack S., Zielecki F., Kochs G., Weber F. Systems to establish bunyavirus genome replication in the absence of transcription. J. Virol. 2013, 87:8205-8212.
49. Kochs G., Janzen C., Hohenberg H., Haller O. Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes. Proc. Natl. Acad. Sci. U S A 2002, 99:3153-3158.
50. Kohl A., Clayton R.F., Weber F., Bridgen A., Randall R.E., Elliott R.M. Bunyamwera virus nonstructural protein NSs counteracts interferon regulatory factor 3-mediated induction of early cell death. J. Virol. 2003, 77:7999-8008.
51. Kohl A., Hart T.J., Noonan C., Royall E., Roberts L.O., Elliott R.M. A bunyamwera virus minireplicon system in mosquito cells. J. Virol. 2004, 78:5679-5685.
52. Kraatz F., Wernike K., Hechinger S., Konig P., Granzow H., Reimann I., Beer M. Deletion mutants of Schmallenberg virus are avirulent and protect from virus challenge. J. Virol. 2015, 89:1825-1837.
53. Kuri T., Habjan M., Penski N., Weber F. Species-independent bioassay for sensitive quantification of antiviral type I interferons. Virol. J. 2010, 7:50.
54. Leonard V.H., Kohl A., Hart T.J., Elliott R.M. Interaction of Bunyamwera orthobunyavirus NSs protein with mediator protein MED8: a mechanism for inhibiting the interferon response. J. Virol. 2006, 80:9667-9675.
55. Li B., Wang Q., Pan X., Fernandez de Castro I., Sun Y., Guo Y., Tao X., Risco C., Sui S.F., Lou Z. Bunyamwera virus possesses a distinct nucleocapsid protein to facilitate genome encapsidation. Proc. Natl. Acad. Sci. U S A 2013, 110:9048-9053.
56. Livonesi M.C., de Sousa R.L., Badra S.J., Figueiredo L.T. In vitro and in vivo studies of the Interferon-alpha action on distinct Orthobunyavirus. Antivir. Res. 2007, 75:121-128.
57. Lozach P.Y., Kuhbacher A., Meier R., Mancini R., Bitto D., Bouloy M., Helenius A. DC-SIGN as a receptor for phleboviruses. Cell Host Microbe 2011, 10:75-88.
58. Marklewitz M., Zirkel F., Rwego I.B., Heidemann H., Trippner P., Kurth A., Kallies R., Briese T., Lipkin W.I., Drosten C., Gillespie T.R., Junglen S. Discovery of a unique novel clade of mosquito-associated bunyaviruses. J. Virol. 2013, 87:12850-12865.
59. McJunkin J.E., de los Reyes E.C., Irazuzta J.E., Caceres M.J., Khan R.R., Minnich L.L., Fu K.D., Lovett G.D., Tsai T., Thompson A. La Crosse encephalitis in children. N. Engl. J. Med. 2001, 344:801-807.
60. Mohamed M., McLees A., Elliott R.M. Viruses in the Anopheles A, Anopheles B, and Tete serogroups in the Orthobunyavirus genus (family Bunyaviridae) do not encode an NSs protein. J. Virol. 2009, 83:7612-7618.
61. Mukherjee P., Woods T.A., Moore R.A., Peterson K.E. Activation of the innate signaling molecule MAVS by bunyavirus infection upregulates the adaptor protein SARM1, leading to neuronal death. Immunity 2013, 38:705-716.
62. Niu F., Shaw N., Wang Y.E., Jiao L., Ding W., Li X., Zhu P., Upur H., Ouyang S., Cheng G., Liu Z.J. Structure of the Leanyer orthobunyavirus nucleoprotein-RNA complex reveals unique architecture for RNA encapsidation. Proc. Natl. Acad. Sci. U S A 2013, 110:9054-9059.
63. Obijeski J.F., Bishop D.H., Palmer E.L., Murphy F.A. Segmented genome and nucleocapsid of La Crosse virus. J. Virol. 1976, 20:664-675.
64. Ogawa Y., Sugiura K., Kato K., Tohya Y., Akashi H. Rescue of Akabane virus (family Bunyaviridae) entirely from cloned cDNAs by using RNA polymerase I. J. Gen. Virol. 2007, 88:3385-3390.
65. Patterson J.L., Holloway B., Kolakofsky D. La Crosse virions contain a primer-stimulated RNA polymerase and a methylated cap-dependent endonuclease. J. Virol. 1984, 52:215-222.
66. Pawaiya R.V.S., Gupta V.K. A review on Schmallenberg virus infection: a newly emerging disease of cattle, sheep and goats. Vet. Med. 2013, 58:516-526.
67. Pichlmair A., Lassnig C., Eberle C.A., Gorna M.W., Baumann C.L., Burkard T.R., Burckstummer T., Stefanovic A., Krieger S., Bennett K.L., Rulicke T., Weber F., Colinge J., Muller M., Superti-Furga G. IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. Nat. Immunol. 2011, 12:624-630.
68. Pollitt E., Zhao J., Muscat P., Elliott R.M. Characterization of Maguari orthobunyavirus mutants suggests the nonstructural protein NSm is not essential for growth in tissue culture. Virology 2006, 348:224-232.
69. Proenca-Modena J.L., Sesti-Costa R., Pinto A.K., Richner J.M., Lazear H.M., Lucas T., Hyde J.L., Diamond M.S. Oropouche virus infection and pathogenesis are restricted by MAVS, IRF-3, IRF-7, and Type I interferon signaling pathways in nonmyeloid cells. J. Virol. 2015, 89:4720-4737.
70. Raju R., Raju L., Kolakofsky D. The translational requirement for complete La Crosse virus mRNA synthesis is cell-type dependent. J. Virol. 1989, 63:5159-5165.
71. Reguera J., Malet H., Weber F., Cusack S. Structural basis for encapsidation of genomic RNA by La Crosse Orthobunyavirus nucleoprotein. Proc. Natl. Acad. Sci. U S A 2013, 110:7246-7251.
72. Reguera J., Weber F., Cusack S. Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription. PLoS Pathog. 2010, 6:e1001101.
73. Sanz-Sanchez L., Risco C. Multilamellar structures and filament bundles are found on the cell surface during bunyavirus egress. PloS One 2013, 8:e65526.
74. Scallan M.F., Elliott R.M. Defective RNAs in mosquito cells persistently infected with Bunyamwera virus. J. Gen. Virol. 1992, 73(Pt 1):53-60.
75. Schlee M. Master sensors of pathogenic RNA-RIG-I like receptors. Immunobiology 2013, 218:1322-1335.
76. Schneider W.M., Chevillotte M.D., Rice C.M. Interferon-stimulated genes: a complex web of host defenses. Ann. Rev. Immunol. 2014, 32:513-545.
77. Schoggins J.W. Interferon-stimulated genes: roles in viral pathogenesis. Curr. Opin. Virol. 2014, 6:40-46.
78. Schoggins J.W., MacDuff D.A., Imanaka N., Gainey M.D., Shrestha B., Eitson J.L., Mar K.B., Richardson R.B., Ratushny A.V., Litvak V., Dabelic R., Manicassamy B., Aitchison J.D., Aderem A., Elliott R.M., Garcia-Sastre A., Racaniello V., Snijder E.J., Yokoyama W.M., Diamond M.S., Virgin H.W., Rice C.M. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 2014, 505:691-695.
79. Shi X., Kohl A., Leonard V.H., Li P., McLees A., Elliott R.M. Requirement of the N-terminal region of orthobunyavirus nonstructural protein NSm for virus assembly and morphogenesis. J. Virol. 2006, 80:8089-8099.
80. Shi X., van Mierlo J.T., French A., Elliott R.M. Visualizing the replication cycle of bunyamwera orthobunyavirus expressing fluorescent protein-tagged Gc glycoprotein. J. Virol. 2010, 84:8460-8469.
81. Sin W.X., Li P., Yeong J.P., Chin K.C. Activation and regulation of interferon-beta in immune responses. Immunol. Res. 2012, 53:25-40.
82. Soldan S.S., Gonzalez-Scarano F. Emerging infectious diseases: the Bunyaviridae. J. Neurovirol. 2005, 11:412-423.
83. Soldan S.S., Plassmeyer M.L., Matukonis M.K., Gonzalez-Scarano F. La Crosse virus nonstructural protein NSs counteracts the effects of short interfering RNA. J. Virol. 2005, 79:234-244.
84. Somesh B.P., Sigurdsson S., Saeki H., Erdjument-Bromage H., Tempst P., Svejstrup J.Q. Communication between distant sites in RNA polymerase II through ubiquitylation factors and the polymerase CTD. Cell 2007, 129:57-68.
85. Streitenfeld H., Boyd A., Fazakerley J.K., Bridgen A., Elliott R.M., Weber F. Activation of PKR by Bunyamwera virus is independent of the viral interferon antagonist NSs. J. Virol. 2003, 77:5507-5511.
86. Svejstrup J.Q. Contending with transcriptional arrest during RNAPII transcript elongation. Trends Biochem. Sci. 2007, 32:165-171.
87. Szemiel A.M., Failloux A.B., Elliott R.M. Role of Bunyamwera Orthobunyavirus NSs protein in infection of mosquito cells. PLoS Negl. Trop. Dis. 2012, 6:e1823.
88. Taylor K.G., Peterson K.E. Innate immune response to La Crosse virus infection. J. Neurovirol. 2014, 20:150-156.
89. Taylor K.G., Woods T.A., Winkler C.W., Carmody A.B., Peterson K.E. Age-dependent myeloid dendritic cell responses mediate resistance to la crosse virus-induced neurological disease. J. Virol. 2014, 88:11070-11079.
90. Thomas D., Blakqori G., Wagner V., Banholzer M., Kessler N., Elliott R.M., Haller O., Weber F. Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist. Journal Biol. Chem. 2004, 279:31471-31477.
91. Upadhyay A.S., Vonderstein K., Pichlmair A., Stehling O., Bennett K.L., Dobler G., Guo J.T., Superti-Furga G., Lill R., Overby A.K., Weber F. Viperin is an iron-sulfur protein that inhibits genome synthesis of tick-borne encephalitis virus via radical SAM domain activity. Cell. Microbiol. 2014, 16:834-848.
92. Utz J.T., Apperson C.S., MacCormack J.N., Salyers M., Dietz E.J., McPherson J.T. Economic and social impacts of La Crosse encephalitis in western North Carolina. Am. J. Trop. Med. Hyg. 2003, 69:509-518.
93. van Knippenberg I., Carlton-Smith C., Elliott R.M. The N-terminus of Bunyamwera orthobunyavirus NSs protein is essential for interferon antagonism. J. Gen. Virol. 2010, 91:2002-2006.
94. van Knippenberg I., Fragkoudis R., Elliott R.M. The transient nature of Bunyamwera orthobunyavirus NSs protein expression: effects of increased stability of NSs protein on virus replication. PloS One 2013, 8:e64137.
95. Varela M., Schnettler E., Caporale M., Murgia C., Barry G., McFarlane M., McGregor E., Piras I.M., Shaw A., Lamm C., Janowicz A., Beer M., Glass M., Herder V., Hahn K., Baumgartner W., Kohl A., Palmarini M. Schmallenberg virus pathogenesis, tropism and interaction with the innate immune system of the host. PLoS Pathog. 2013, 9:e1003133.
96. Vasconcelos H.B., Nunes M.R., Casseb L.M., Carvalho V.L., Pinto da Silva E.V., Silva M., Casseb S.M., Vasconcelos P.F. Molecular epidemiology of Oropouche virus, Brazil. Emerg. Infect. Dis. 2011, 17:800-806.
97. Verbruggen P., Ruf M., Blakqori G., Overby A.K., Heidemann M., Eick D., Weber F. Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II. J. Biol. Chem. 2011, 286:3681-3692.
98. Walter C.T., Barr J.N. Recent advances in the molecular and cellular biology of bunyaviruses. J. Gen. Virol. 2011, 92:2467-2484.
99. Weber F., Bridgen A., Fazakerley J.K., Streitenfeld H., Kessler N., Randall R.E., Elliott R.M. Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. J. Virol. 2002, 76:7949-7955.
100. Weber F., Dunn E.F., Bridgen A., Elliott R.M. The Bunyamwera virus nonstructural protein NSs inhibits viral RNA synthesis in a minireplicon system. Virology 2001, 281:67-74.
101. Weber F., Wagner V., Rasmussen S.B., Hartmann R., Paludan S.R. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 2006, 80:5059-5064.
102. Weber M., Gawanbacht A., Habjan M., Rang A., Borner C., Schmidt A.M., Veitinger S., Jacob R., Devignot S., Kochs G., Garcia-Sastre A., Weber F. Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling. Cell Host Microbe 2013, 13:336-346.
103. Weber M., Sediri H., Felgenhauer U., Binzen I., Banfer S., Jacob R., Brunotte L., Garcia-Sastre A., Schmid-Burgk J.L., Schmidt T., Hornung V., Kochs G., Schwemmle M., Klenk H.D., Weber F. Influenza virus adaptation PB2-627K Modulates Nucleocapsid Inhibition By The Pathogen Sensor RIG-I. Cell Host Microbe 2015, 17:309-319.
104. Weber M., Weber F. RIG-I-like receptors and negative-strand RNA viruses: RLRly bird catches some worms. Cytokine Growth Factor Rev. 2014, 25:621-628.
105. Weber M., Weber F. Segmented negative-strand RNA viruses and RIG-I: divide (your genome) and rule. Curr. Opin. Microbiol. 2014, 20:96-102.
106. Yim H.C., Williams B.R. Protein kinase R and the inflammasome. J. Interf. Cytokine Res.: Off. J. Int. Soc. Interf. Cytokine Res. 2014, 34:447-454.
107. Yoneyama M., Onomoto K., Jogi M., Akaboshi T., Fujita T. Viral RNA detection by RIG-I-like receptors. Curr. Opin. Immunol. 2015, 32C:48-53.